Dimerix optimises DMX-200 dosage - Nine

Dimerix optimises DMX-200 dosage
Nine
Dimerix has received top-line results from a recent pharmacokinetic study of an extended release tablet formulation for their DMX-200 program targeting Chronic Kidney Disease. The study found a newly formulated extended release tablet of DMX-200 taken ...